NCT01184872 - Study to Compare Efficacy and Safety of Daptomycin in Elderly Patients With Complicated Skin and Soft Tissue Infections | Biotech Hunter

Enrollment

120

Participants

Timeline

Start Date

March 31, 2010

Primary Completion Date

March 31, 2011

Study Completion Date

March 31, 2011

Conditions

Infections

Interventions

DRUG

Daptomycin

"Patients with bacteremia: Daptomycin 6 mg/Kg intravenous once daily for at least 5 days and up to 28 days.~Patients without bacteremia: Daptomycin 4 mg/Kg intravenous once daily for at least 5 days and up to 14 days."

DRUG

Vancomycin or Semi-Synthetic Penicillins (SSPs)

"Patients with bacteremia: Vancomycin 1 g intravenous twice daily or Semi-Synthetic Penicillins 2 g intravenous every 4 hours for at least 5 days and up to 28 days.~Patients without bacteremia: Vancomycin 1 g intravenous twice daily or Semi-Synthetic Penicillins 2 g intravenous every 6 hours for at least 5 days and up to 14 days."

Trial Locations (17)

Unknown

Novartis Investigative Site, Graz

Novartis Investigative Site, Vienna

Novartis Investigative Site, Bochum

Novartis Investigative Site, Essen

Novartis Investigative Site, Homburg

Novartis Investigative Site, Magdeburg

Novartis Investigative Site, Mannheim

Novartis Investigative Site, Münster

Novartis Investigative Site, Tübingen

Novartis Investigative Site, Pisa

Novartis Investigative Site (1), Moscow

Novartis Investigative Site, Novosibirsk

Novartis Investigative Site (2), Saint Petersburg

Novartis Investigative Site, Yaroslavi

Novartis Investigative Site (1), Madrid

Novartis Investigative Site, Santander

Novartis Investigative Site, Seville